|
ARCT Arcturus Therapeutics Holdings Inc 1768224 |
| Balance Sheet |
|
Current Assets
|
$197,161,000.00 |
|
Assets
|
$224,310,000.00 |
|
Current Liabilities
|
$33,536,000.00 |
|
Liabilities
|
$52,502,000.00 |
|
Equity
|
$171,808,000.00 |
|
Shares Out
|
28423000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-39,351,000.00 |
|
Investing Cash Flow
|
$52,000.00 |
| Market Analysis |
Market Cap
|
$312,368,770.00 |
|
Price
|
$10.99 |
|
BVPS
|
6.04 |
|
PB
|
1.82 |
|
EPS
|
-0.84 |
|
PS
|
26.39 |
|
FCF
|
$-39,351,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
| Apr |
May |
Jun |
| 2026-03-03 |
-1.03 |
|
|
2026-05-07 |
-0.95 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.34 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.49 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARCT documents filed with the SEC.
ARCT Filings
Clear